perspectives on the management of low and high-risk mds
Published 2 years ago • 65 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:20
the current standard of care for patients with lower-risk mds
-
2:37
esas for the management of lower-risk mds
-
1:02
emerging treatment options for lower- and higher-risk mds and ongoing trials
-
1:04
the future of mds management
-
0:35
mds: the role of the multidisciplinary team
-
49:25
myelodysplastic syndrome (mds) and anemia
-
4:16
how are high risk and low risk mds defined? #mds
-
3:54
life with mds: jill shares how her family helped her overcome an mds diagnosis
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
1:16
state of the art: mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
1:41
an overview of the mds diagnosis pathway
-
1:32
next-generation sequencing for low-risk mds
-
1:30
the prognostic value of patient-reported outcomes in mds
-
3:11
clinical characteristics of h-mds
-
2:43
novel therapies in the future of mds treatment
-
1:18
the importance risk stratification to enable risk-adapted therapy in mds & cmml
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:42
unmet needs in high-risk mds and ongoing trials in the field
-
4:16
pre-mds states: identifying patients at risk and using modern tools to improve prognosis
-
2:04
state-of-the-art treatment for hr-mds
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology